<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Evaluation of epistaxis in children</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Evaluation of epistaxis in children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Evaluation of epistaxis in children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna H Messner, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Glenn C Isaacson, MD, FAAP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joshua Nagler, MD, MHPEd</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">James F Wiley, II, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 20, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Epistaxis is common in children. Childhood nosebleeds are rarely severe and seldom require hospital admission [<a href="#rid1">1</a>]. Nonetheless, frequent minor nosebleeds can be both bothersome and alarming for caregivers and children.</p><p>The evaluation of epistaxis in children will be reviewed here. The epidemiology, etiology, and management of epistaxis in children are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6452.html" rel="external">"Causes of epistaxis in children"</a> and  <a class="medical medical_review" href="/z/d/html/6484.html" rel="external">"Management of epistaxis in children"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">OVERVIEW</span><span class="headingEndMark"> — </span>Although nosebleeds in children are rarely life threatening, the initial evaluation should focus upon the respiratory and hemodynamic stability of the patient rather than the bleeding. Normal appearance, vital signs, and respiratory function are evidence that the examiner can safely attend to the presenting complaint. On the other hand, abnormalities in these indices may signal an emergency. Airway intervention and fluid resuscitation are sometimes necessary in massive epistaxis. (See <a class="local">'Emergency assessment'</a> below.)</p><p>The goal of the evaluation is to determine the site and etiology of bleeding. Nosebleeds in children have a variety of etiologies, ranging from self-limited mucosal irritation to life-threatening neoplasms  (<a class="graphic graphic_table graphicRef67540" href="/z/d/graphic/67540.html" rel="external">table 1</a>). Distinguishing between local and systemic causes of bleeding is critical to the institution of timely and appropriate therapy. (See  <a class="medical medical_review" href="/z/d/html/6452.html" rel="external">"Causes of epistaxis in children"</a> and  <a class="medical medical_review" href="/z/d/html/6484.html" rel="external">"Management of epistaxis in children"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">EMERGENCY ASSESSMENT</span><span class="headingEndMark"> — </span>Rapid assessment of general appearance, vital signs, airway stability, and mental status are necessary to identify children with respiratory or hemodynamic instability who require airway intervention and/or fluid resuscitation [<a href="#rid2">2</a>]. Airway intervention is needed for patients who are spitting or regurgitating blood to the point that they cannot maintain oxygenation or their airway. (See  <a class="medical medical_review" href="/z/d/html/6316.html" rel="external">"Technique of emergency endotracheal intubation in children"</a> and  <a class="medical medical_review" href="/z/d/html/6389.html" rel="external">"Hypovolemic shock in children in resource-abundant settings: Initial evaluation and management", section on 'Fluid resuscitation'</a> and  <a class="medical medical_review" href="/z/d/html/6484.html" rel="external">"Management of epistaxis in children"</a>.)</p><p>Rapid assessment and stabilization is followed immediately by attempts to identify the source of bleeding and initiation of measures to control it, usually in consultation with otolaryngology [<a href="#rid3">3</a>]. Blood factors or platelets should be administered to patients who have bleeding disorders that can be treated with such products. The remainder of the evaluation is undertaken after the patient is stabilized.</p><p class="headingAnchor" id="H4"><span class="h1">HISTORY</span><span class="headingEndMark"> — </span>Important aspects of the history in a child with epistaxis include [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>How old is the child?</strong> </p><p></p><p class="bulletIndent1">Epistaxis is rare in children younger than two years (approximately 1 per 10,000) and should prompt consideration of trauma (intentional or unintentional) or serious illness (eg, thrombocytopenia)  (<a class="graphic graphic_table graphicRef67540" href="/z/d/graphic/67540.html" rel="external">table 1</a>). Epistaxis in this age group has also been associated with asphyxiation, either intentional or unintentional [<a href="#rid4">4-7</a>] Thus, presence of epistaxis in children younger than two years of age should prompt assessment for other signs of child abuse  (<a class="graphic graphic_table graphicRef109401" href="/z/d/graphic/109401.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef119441" href="/z/d/graphic/119441.html" rel="external">table 3</a>) [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>When did the bleeding begin?</strong> </p><p></p><p class="bulletIndent1">Prolonged bleeding despite correctly applied direct compression may be suggestive of a bleeding disorder [<a href="#rid9">9-11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Has there been any bleeding or unusual bruising elsewhere in the body? </strong></p><p></p><p class="bulletIndent1">Bleeding elsewhere in the body, particularly if it is prolonged, is suggestive of a bleeding disorder. Areas of ecchymosis may indicate a bleeding disorder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Any prior visits to the emergency department (ED) for epistaxis?</strong> </p><p></p><p class="bulletIndent1">Prior ED visits are associated with an increased risk of a bleeding diathesis [<a href="#rid6">6</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Is it bilateral or unilateral?</strong> </p><p></p><p class="bulletIndent1">Unilateral bleeding indicates that there may be an isolated lesion or minor trauma, whereas bilateral bleeding is more suggestive of general mucosal irritation, systemic etiology or major nasal trauma. (See  <a class="medical medical_review" href="/z/d/html/6452.html" rel="external">"Causes of epistaxis in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>How much blood has been lost?</strong> </p><p></p><p class="bulletIndent1">Estimation of the quantity of blood loss is difficult; the quantity of bleeding in posterior epistaxis is often underestimated because much of the blood is swallowed [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Is there blood in the mouth or vomitus?</strong> </p><p></p><p class="bulletIndent1">Posterior bleeding is suggested by initial awareness of bleeding in the back of the throat and/or swallowed blood. Patients with swallowed blood may present with complaints of hematemesis or melena [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>What measures were taken to stop the bleeding?</strong> </p><p></p><p class="bulletIndent1">Bleeding that is difficult to control with anterior pressure may indicate a bleeding disorder or a posterior source of bleeding [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Is there a history of trauma (including nose picking)?</strong> </p><p></p><p class="bulletIndent1">Some providers find that asking children which finger they use to pick their nose elicits a more honest answer about nose picking [<a href="#rid3">3</a>]. Nasal trauma (ie, a broken nose) usually causes epistaxis that in most cases resolves spontaneously. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Is there a history of nasal congestion, discharge, or obstruction? Has there been an insertion of a foreign body?</strong> </p><p></p><p class="bulletIndent1">Bloody discharge from one side of the nose suggests the possibility of a foreign body in the nose, particularly if the nasal discharge is foul smelling. In patients with a button battery in the nose and associated tissue necrosis, the discharge may also have a black color; in addition, facial pain and swelling may be present (see  <a class="medical medical_review" href="/z/d/html/83377.html" rel="external">"Diagnosis and management of intranasal foreign bodies"</a>). Nasal obstruction with mucopurulent drainage and facial pain, especially during the winter suggests chronic sinusitis. Progressively worsening nasal obstruction, particularly if it is associated with epistaxis, implies possible nasal tumor  (<a class="graphic graphic_table graphicRef67540" href="/z/d/graphic/67540.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/7525.html" rel="external">"Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/7528.html" rel="external">"Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Is there a recent history of nasal surgery?</strong> </p><p></p><p class="bulletIndent1">Occasionally children will have epistaxis after an adenoidectomy or other nasal surgery; post-operative epistaxis usually is self-limiting but can require intervention by the otolaryngologist.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Are there associated symptoms?</strong> </p><p></p><p class="bulletIndent1">Headaches and/or facial pain may be related to an intracranial mass. Fever and hepatomegaly suggest the possibility of dengue hemorrhagic fever for patients residing in or traveling from endemic regions. Hearing loss and cranial neuropathies may suggest rhabdomyosarcoma. Hearing loss, torticollis, trismus, unilateral cervical adenopathy, retrobulbar or ear pain, and neck pain may suggest nasopharyngeal carcinoma. (See  <a class="medical medical_review" href="/z/d/html/6452.html" rel="external">"Causes of epistaxis in children"</a>.)</p><p></p><p>Past medical history, family history, and review of systems should include information regarding:</p><p class="bulletIndent1"><span class="glyph">●</span>Allergies.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Medications (particularly nasal corticosteroids, <a class="drug drug_pediatric" data-topicid="12829" href="/z/d/drug information/12829.html" rel="external">aspirin</a> and <a class="drug drug_pediatric" data-topicid="13371" href="/z/d/drug information/13371.html" rel="external">ibuprofen</a> [<a href="#rid12">12</a>]), drugs of abuse (cocaine, heroin, inhalants), and complementary/alternative therapies (ie, ginkgo biloba).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Number, frequency, and seasonality of previous episodes. Intermittent epistaxis may be caused by changes in the weather, allergies, low humidification of inspired air; colonization with pathologic bacteria (eg, <em>Staphylococcus aureus</em>). Intermittent epistaxis may also be related to menses [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>History of easy bruising or bleeding problems in the patient or family.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Family history of hereditary hemorrhagic telangiectasia [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the child younger than two years of age, history of apparent life-threatening events or sibling death [<a href="#rid7">7</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h1">EXAMINATION</span></p><p class="headingAnchor" id="H6"><span class="h2">Preparation</span><span class="headingEndMark"> — </span>Examination of a child with epistaxis can be difficult and may be facilitated by the application of a topical vasoconstricting and/or anesthetic agent (eg, <a class="drug drug_pediatric" data-topicid="12551" href="/z/d/drug information/12551.html" rel="external">lidocaine</a> alone or lidocaine mixed with a vasoconstricting agent, such as 0.025 percent <a class="drug drug_pediatric" data-topicid="12670" href="/z/d/drug information/12670.html" rel="external">oxymetazoline</a> hydrochloride) [<a href="#rid15">15</a>]. The vasoconstricting agent can be applied with a spray bottle or a cotton pledget (placed into the nose with forceps and removed after five minutes).</p><p>Along with topical anesthesia, some children may need anxiolysis or mild sedation. (See  <a class="medical medical_review" href="/z/d/html/85542.html" rel="external">"Procedural sedation in children: Selection of medications"</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">General examination</span><span class="headingEndMark"> — </span>Children with epistaxis should undergo a complete general examination, with special attention to hemodynamic compromise, signs of systemic causes of bleeding, and asphyxiation [<a href="#rid3">3,7,16</a>]. The following aspects are particularly important:</p><p class="bulletIndent1"><span class="glyph">●</span>Vital signs, including blood pressure and heart rate</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Malaise suggestive of hypoxia and/or acidosis after asphyxiation [<a href="#rid7">7</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pallor (as an indication of blood loss or anemia) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Respiratory distress, poor skin perfusion with altered color (eg, cyanosis or grey color) due to asphyxiation [<a href="#rid7">7</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Petechiae, bruising, gingival bleeding; hemotympanum may be present due to the reflux of blood into the eustachian tube [<a href="#rid17">17</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Examination of the oropharynx (for signs of posterior bleeding)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mucocutaneous telangiectasias, hemangiomas</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Enlarged lymph nodes, organomegaly, petechiae, pallor (as indications of hematologic disease or malignancy)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Icterus as a sign of liver disease (with secondary coagulopathy)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Visual acuity and extraocular movements should be tested in children with a history of facial trauma</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Orbit (blood can reflux up the nasolacrimal duct and appear in the medial canthus and along the lower eyelid)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal bruising, oral injury, burns, or other findings of physical child abuse, especially in children younger than two years of age (see  <a class="medical medical_review" href="/z/d/html/103420.html" rel="external">"Physical child abuse: Recognition"</a>)</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Nasopharynx</span><span class="headingEndMark"> — </span>Most nosebleeds in children are anterior. Posterior bleeds are important to identify because they may require more extensive management [<a href="#rid3">3</a>]. Specific sites to be examined include the nasal septum (Kiesselbach's plexus, presence of a septal perforation), nasal cavity, inferior turbinates, and nasopharynx  (<a class="graphic graphic_figure graphicRef54180" href="/z/d/graphic/54180.html" rel="external">figure 1</a>).</p><p>Initial inspection may be accomplished by using one's thumb to push the tip of the nose upward. This permits examination of the vestibule, the anterior portion of the septum, and the anterior portion of the inferior turbinate [<a href="#rid3">3</a>]. A more thorough inspection for anterior septal bleeding can be completed by anterior rhinoscopy using a headlight, or head mirror and nasal speculum. Alternatively, an otoscope with a large tip may be used in the young child who has difficulty holding still. The area of Kiesselbach's plexus should be inspected first since it is the source of the majority of nosebleeds. This area should be examined for active bleeding, scabs, ulcerations, erosions, or prominent blood vessels.</p><p>Failure to identify a source of anterior bleeding may indicate posterior bleeding. Examination for more posterior bleeding is usually performed by an otolaryngologist with flexible or rigid fiberoptic endoscopy [<a href="#rid16">16</a>].</p><p>In addition to evaluation for a bleeding source, examination of the nose and nasopharynx should include inspection for other potential causes of bleeding including [<a href="#rid3">3</a>] (see  <a class="medical medical_review" href="/z/d/html/6452.html" rel="external">"Causes of epistaxis in children"</a>): </p><p class="bulletIndent1"><span class="glyph">●</span>Foreign bodies  (<a class="graphic graphic_picture graphicRef86433" href="/z/d/graphic/86433.html" rel="external">picture 1</a>) (see  <a class="medical medical_review" href="/z/d/html/83377.html" rel="external">"Diagnosis and management of intranasal foreign bodies"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mucosal inflammation/lesions/crusting (suggestive of bacterial colonization) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Masses (tumors)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rhinitis (infectious or allergic)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vascular anomalies (telangiectasia, hemangioma)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Juvenile angiofibromas (especially in teenage boys)  (<a class="graphic graphic_diagnosticimage graphicRef76702" href="/z/d/graphic/76702.html" rel="external">image 1</a>)</p><p></p><p class="headingAnchor" id="H9"><span class="h1">LABORATORY EVALUATION</span><span class="headingEndMark"> — </span>Laboratory evaluation is <strong>not</strong> indicated in the majority of children with self-limited epistaxis. However, based upon observational and anecdotal evidence, laboratory evaluation is appropriate in the following children: </p><p class="bulletIndent1"><span class="glyph">●</span>Directly observed prolonged epistaxis (eg, &gt;30 minutes) despite correctly applied local pressure</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Epistaxis refractory to acute measures to stop bleeding </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Epistaxis in children younger than two years of age</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Epistaxis more than two to three times per week for several weeks</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>History or examination findings suggestive of a bleeding disorder or other systemic disease [<a href="#rid2">2</a>]</p><p></p><p>Consultation with a hematologist before ordering labs can ensure that all of the necessary tests are performed, since sophisticated testing may be required to detect mild bleeding disorders. (See  <a class="medical medical_review" href="/z/d/html/5936.html" rel="external">"Approach to the child with bleeding symptoms"</a>.)</p><p>Laboratory evaluation for bleeding disorder may include  (<a class="graphic graphic_table graphicRef67121" href="/z/d/graphic/67121.html" rel="external">table 4</a> and <a class="graphic graphic_algorithm graphicRef60745" href="/z/d/graphic/60745.html" rel="external">algorithm 1</a>) [<a href="#rid3">3,9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Blood type and screen/cross-match for patients with severe bleeding who may require transfusion</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood count with platelet count and examination of the smear  (<a class="graphic graphic_algorithm graphicRef82633" href="/z/d/graphic/82633.html" rel="external">algorithm 2</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prothrombin time (PT)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Activated partial thromboplastin time (PTT)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prothrombin time international normalized ratio (INR) if the child is receiving anticoagulation therapy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for von Willebrand disease, if clinically indicated. Epistaxis may be the sole indication of von Willebrand disease. (see  <a class="medical medical_review" href="/z/d/html/1307.html" rel="external">"Clinical presentation and diagnosis of von Willebrand disease"</a>)</p><p></p><p>Additional diagnostic studies for physical child abuse are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6600.html" rel="external">"Physical child abuse: Diagnostic evaluation and management", section on 'Laboratory studies'</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">RADIOLOGIC EVALUATION</span><span class="headingEndMark"> — </span>If a nasal foreign body is suspected, a lateral face radiograph can be performed to evaluate for a button battery or other radio-opaque objects. (See  <a class="medical medical_review" href="/z/d/html/83377.html" rel="external">"Diagnosis and management of intranasal foreign bodies", section on 'Diagnosis'</a>.)</p><p>Contrast-enhanced computed tomography or magnetic resonance imaging should be performed in children with epistaxis if a mass is visualized or suspected. (See  <a class="medical medical_review" href="/z/d/html/6452.html" rel="external">"Causes of epistaxis in children"</a>.)</p><p>Consultation with a pediatric oncologist and/or otolaryngologist is warranted if neoplasm is suspected. Such consultation can ensure that the appropriate laboratory evaluation, radiographs, and histopathologic studies are obtained.</p><p>Imaging in child with suspected physical child abuse is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6600.html" rel="external">"Physical child abuse: Diagnostic evaluation and management", section on 'Imaging'</a>.) </p><p class="headingAnchor" id="H11"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/15461.html" rel="external">"Patient education: Nosebleeds (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/z/d/html/2722.html" rel="external">"Patient education: Nosebleeds (epistaxis) (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H12"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emergency assessment</strong> – Although nosebleeds are rarely life threatening, the initial evaluation should focus on the respiratory and hemodynamic stability of the patient. Rapid assessment of general appearance, vital signs, airway stability, and mental status are necessary to identify children with epistaxis who require airway intervention and/or fluid resuscitation. Identification of the source of bleeding and initiation of bleeding control measures follow immediately. (See <a class="local">'Emergency assessment'</a> above and  <a class="medical medical_review" href="/z/d/html/6484.html" rel="external">"Management of epistaxis in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Evaluation of children with epistaxis should determine the site and etiology of bleeding. Nosebleeds in children have a variety of etiologies, ranging from self-limited mucosal irritation to life-threatening neoplasms  (<a class="graphic graphic_table graphicRef67540" href="/z/d/graphic/67540.html" rel="external">table 1</a>). (See <a class="local">'Overview'</a> above and  <a class="medical medical_review" href="/z/d/html/6452.html" rel="external">"Causes of epistaxis in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>History</strong> – Features that increase the likelihood of a cause other than local mucosal trauma include (see <a class="local">'History'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Young age (&lt;2 years old without clear history of trauma)</p><p class="bulletIndent2"><span class="glyph">•</span>Prolonged bleeding (eg, &gt;30 minutes) despite appropriate nasal compression  (<a class="graphic graphic_figure graphicRef138448" href="/z/d/graphic/138448.html" rel="external">figure 2</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Bleeding elsewhere in the body or unusual bruising</p><p class="bulletIndent2"><span class="glyph">•</span>Blood initially noted in the back of throat (suggests posterior bleeding site)</p><p class="bulletIndent2"><span class="glyph">•</span>Hematemesis (suggests copious anterior or posterior bleeding)</p><p class="bulletIndent2"><span class="glyph">•</span>Recurrent epistaxis</p><p class="bulletIndent2"><span class="glyph">•</span>Bilateral epistaxis </p><p class="bulletIndent2"><span class="glyph">•</span>Family history of a bleeding disorder</p><p></p><p class="bulletIndent1">Epistaxis is associated with asphyxiation in children younger than two years of age with epistaxis and no traumatic injury or bleeding disorder. Careful history, physical examination, and when physical child abuse is suspected, additional evaluation in consultation with a multidisciplinary child abuse team is warranted in such patients. The evaluation of physical child abuse is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6600.html" rel="external">"Physical child abuse: Diagnostic evaluation and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination</strong> – Application of a topical vasoconstricting and/or anesthetic agent (eg, <a class="drug drug_pediatric" data-topicid="12551" href="/z/d/drug information/12551.html" rel="external">lidocaine</a> alone or lidocaine mixed with a vasoconstricting agent, such as 0.025 percent <a class="drug drug_pediatric" data-topicid="12670" href="/z/d/drug information/12670.html" rel="external">oxymetazoline</a> hydrochloride) may facilitate examination. For some children, anxiolysis, sedation and/or analgesia may be beneficial. (See <a class="local">'Preparation'</a> above.)</p><p></p><p class="bulletIndent1">Important findings of serious illness include (see <a class="local">'General examination'</a> above): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Respiratory distress </p><p class="bulletIndent2"><span class="glyph">•</span>Pallor, petechiae/purpura, bruising, or bleeding from the gums</p><p class="bulletIndent2"><span class="glyph">•</span>Posterior bleeding</p><p></p><p class="bulletIndent1">The nasal and nasopharyngeal examination is directed toward determining the site and cause of bleeding such as mucosal abnormalities, foreign bodies, masses, anatomic abnormalities, or vascular abnormalities. (See <a class="local">'Nasopharynx'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory studies</strong> – Laboratory studies are not indicated for most children with self-limited epistaxis. However, evaluation for bleeding disorder (complete blood count, with platelet count and examination of the peripheral smear, prothrombin time, and activated partial thromboplastin time) is indicated in patients with frequent recurrent nosebleeds, severe nosebleeds that are difficult to control, and those with personal or family history suggestive of a bleeding disorder. Consultation with a hematologist prior to ordering blood studies can ensure that all of the necessary tests are performed, since sophisticated testing may be required to detect mild bleeding disorders. (See <a class="local">'Laboratory evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging</strong> – If an intranasal mass is seen or suspected, contrast-enhanced computed tomography or magnetic resonance imaging is indicated. (See <a class="local">'Radiologic evaluation'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Brown NJ, Berkowitz RG. Epistaxis in healthy children requiring hospital admission. Int J Pediatr Otorhinolaryngol 2004; 68:1181.</a></li><li class="breakAll">Delgado EM, Nadel FM. Epistaxis. In: Fleisher and Ludwig's Textbook of Pediatric Emergency Medicine, 8th edition, Shaw KN, Bachur RG (Eds), Wolters Kluwer, Philadelphia 2021. p.166.</li><li><a class="nounderline abstract_t">Svider P, Arianpour K, Mutchnick S. Management of Epistaxis in Children and Adolescents: Avoiding a Chaotic Approach. Pediatr Clin North Am 2018; 65:607.</a></li><li><a class="nounderline abstract_t">McIntosh N, Mok JY, Margerison A. Epidemiology of oronasal hemorrhage in the first 2 years of life: implications for child protection. Pediatrics 2007; 120:1074.</a></li><li><a class="nounderline abstract_t">Hey E. Sudden oronasal bleeding in a young child. Acta Paediatr 2008; 97:1327.</a></li><li><a class="nounderline abstract_t">Elden L, Reinders M, Witmer C. Predictors of bleeding disorders in children with epistaxis: value of preoperative tests and clinical screening. Int J Pediatr Otorhinolaryngol 2012; 76:767.</a></li><li><a class="nounderline abstract_t">Rees P, Kemp A, Carter B, Maguire S. A Systematic Review of the Probability of Asphyxia in Children Aged &lt;2 Years with Unexplained Epistaxis. J Pediatr 2016; 168:178.</a></li><li><a class="nounderline abstract_t">Béquignon E, Teissier N, Gauthier A, et al. Emergency Department care of childhood epistaxis. Emerg Med J 2017; 34:543.</a></li><li><a class="nounderline abstract_t">Sandoval C, Dong S, Visintainer P, et al. Clinical and laboratory features of 178 children with recurrent epistaxis. J Pediatr Hematol Oncol 2002; 24:47.</a></li><li><a class="nounderline abstract_t">Kime C, Klima J, Rose MJ, O'Brien SH. Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals. Pediatrics 2013; 131:880.</a></li><li><a class="nounderline abstract_t">O'Brien SH. Common management issues in pediatric patients with mild bleeding disorders. Semin Thromb Hemost 2012; 38:720.</a></li><li><a class="nounderline abstract_t">Chong LY, Head K, Hopkins C, et al. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev 2016; 4:CD011996.</a></li><li><a class="nounderline abstract_t">Kamble P, Saxena S, Kumar S. Nasal bacterial colonization in cases of idiopathic epistaxis in children. Int J Pediatr Otorhinolaryngol 2015; 79:1901.</a></li><li><a class="nounderline abstract_t">Gonzalez CD, Mcdonald J, Stevenson DA, et al. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia. Laryngoscope 2018; 128:1714.</a></li><li><a class="nounderline abstract_t">Krempl GA, Noorily AD. Use of oxymetazoline in the management of epistaxis. Ann Otol Rhinol Laryngol 1995; 104:704.</a></li><li><a class="nounderline abstract_t">Tunkel DE, Anne S, Payne SC, et al. Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary. Otolaryngol Head Neck Surg 2020; 162:8.</a></li><li><a class="nounderline abstract_t">Hurtado TR, Zeger WG. Hemotympanums secondary to spontaneous epistaxis in a 7-year-old. J Emerg Med 2004; 26:61.</a></li></ol></div><div id="topicVersionRevision">Topic 6451 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15302149" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Epistaxis in healthy children requiring hospital admission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15302149" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Epistaxis in healthy children requiring hospital admission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29803286" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Management of Epistaxis in Children and Adolescents: Avoiding a Chaotic Approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17893187" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Epidemiology of oronasal hemorrhage in the first 2 years of life: implications for child protection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18647276" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Sudden oronasal bleeding in a young child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22459034" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Predictors of bleeding disorders in children with epistaxis: value of preoperative tests and clinical screening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26507155" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A Systematic Review of the Probability of Asphyxia in Children Aged&lt;2 Years with Unexplained Epistaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27542804" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Emergency Department care of childhood epistaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11902740" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinical and laboratory features of 178 children with recurrent epistaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23569091" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23034827" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Common management issues in pediatric patients with mild bleeding disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27115217" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26384831" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Nasal bacterial colonization in cases of idiopathic epistaxis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29171658" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7661519" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Use of oxymetazoline in the management of epistaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31910122" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14751480" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Hemotympanums secondary to spontaneous epistaxis in a 7-year-old.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
